Latest Huntington's disease Stories
-- CHOP Gene Therapy Expert Fine-Tunes Protein Signals, Improves Motor Function and Reduces Brain Shrinkage in a Neurological Disorder -- PHILADELPHIA, Jan.
Blooming poinsettias and amaryllis can bring joy long after the Holidays are over.
Novel ZFP Therapeutic Approach Selectively Represses Expression of Huntington's Disease-Causing Gene Variant in Patient-Derived Cells and Animal Models RICHMOND, Calif., Nov.
Scientists have described a way to convert human skin cells directly into a specific type of brain cell affected by Huntington’s disease, an ultimately fatal neurodegenerative disorder.
-- Enrollment in Huntington's Trial Suspended Pending Further Assessment of Preclinical Data -- SEATTLE, Oct.
Woody Guthrie Center to house artist Phil Ochs' work TULSA, Okla., Sept.
"Rusty's Story" is an FBR Media documentary about one family's harrowing journey with Huntington's disease and medicine's decades-long search for a cure. WASHINGTON, Aug.
Researchers believe they have learned how mutations in the gene that causes Huntington’s disease kill brain cells, a finding that could open new opportunities for treating the fatal disorder.
Lack of Disease-Modifying Therapies is Expected to Remain a Critical Unmet Need and Provides Ample Opportunity for Developers, According to Findings from Decision Resources Group BURLINGTON,
Research presented by Dr. Lynn Raymond, from the University of British Columbia, shows that blocking a specific class of glutamate receptors, called extrasynaptic NMDA receptors, can improve motor learning and coordination, and prevent cell death in animal models of Huntington disease.